» Articles » PMID: 9305847

A Model for P53-induced Apoptosis

Overview
Journal Nature
Specialty Science
Date 1997 Sep 26
PMID 9305847
Citations 674
Authors
Affiliations
Soon will be listed here.
Abstract

The inactivation of the p53 gene in a large proportion of human cancers has inspired an intense search for the encoded protein's physiological and biological properties. Expression of p53 induces either a stable growth arrest or programmed cell death (apoptosis). In human colorectal cancers, the growth arrest is dependent on the transcriptional induction of the protein p21WAF1/CIP1 , but the mechanisms underlying the development of p53-dependent apoptosis are largely unknown. As the most well documented biochemical property of p53 is its ability to activate transcription of genes, we examined in detail the transcripts induced by p53 expression before the onset of apoptosis. Of 7,202 transcripts identified, only 14 (0.19%) were found to be markedly increased in p53-expressing cells compared with control cells. Strikingly, many of these genes were predicted to encode proteins that could generate or respond to oxidative stress, including one that is implicated in apoptosis in plant meristems. These observations stimulated additional biochemical and pharmacological experiments suggesting that p53 results in apoptosis through a three-step process: (1) the transcriptional induction of redox-related genes; (2) the formation of reactive oxygen species; and (3) the oxidative degradation of mitochondrial components, culminating in cell death.

Citing Articles

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53.

Taritsa I, Fossel E Front Pharmacol. 2025; 16:1529483.

PMID: 39944631 PMC: 11813898. DOI: 10.3389/fphar.2025.1529483.


SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.

Alfarsi L, Ansari R, Erkan B, Fakroun A, Craze M, Aleskandarany M Sci Rep. 2025; 15(1):2805.

PMID: 39843491 PMC: 11754656. DOI: 10.1038/s41598-025-87292-1.


(Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes.

Zuo Z, Wen R, Jing S, Chen X, Liu R, Xue J Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770537 PMC: 11677753. DOI: 10.3390/ph17121695.


Cysteamine dioxygenase (ADO) governs cancer cell mitochondrial redox homeostasis through proline metabolism.

Lee S, Pyo A, Mohammadi H, Zhang J, Dvorkin-Gheva A, Malbeteau L Sci Adv. 2024; 10(40):eadq0355.

PMID: 39356760 PMC: 11446280. DOI: 10.1126/sciadv.adq0355.


Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules.

Chen L, Singha Roy S, Jadhav A, Wang W, Chen P, Bishop T ACS Chem Biol. 2024; 19(9):1918-1929.

PMID: 39250704 PMC: 11421428. DOI: 10.1021/acschembio.4c00438.